SPRB

Spruce Biosciences (SPRB)

Spruce Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SPRB

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/03	20 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SPRB	Spruce Biosciences Inc
2024/06/03	20 : 00	Business Wire	Spruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024	NASDAQ:SPRB	Spruce Biosciences Inc
2024/05/25	05 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SPRB	Spruce Biosciences Inc
2024/05/25	05 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SPRB	Spruce Biosciences Inc
2024/05/25	05 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SPRB	Spruce Biosciences Inc
2024/05/25	05 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SPRB	Spruce Biosciences Inc
2024/05/25	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SPRB	Spruce Biosciences Inc
2024/05/24	05 : 05	Business Wire	Spruce Biosciences to Participate in the Jefferies Global Healthcare Conference	NASDAQ:SPRB	Spruce Biosciences Inc
2024/05/23	05 : 14	Business Wire	Spruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine Society	NASDAQ:SPRB	Spruce Biosciences Inc
2024/05/14	05 : 09	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SPRB	Spruce Biosciences Inc
2024/05/14	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SPRB	Spruce Biosciences Inc
2024/05/14	05 : 01	Business Wire	Spruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates	NASDAQ:SPRB	Spruce Biosciences Inc
2024/05/02	05 : 05	Business Wire	Spruce Biosciences to Participate in May Investor Conferences	NASDAQ:SPRB	Spruce Biosciences Inc
2024/05/01	05 : 05	Business Wire	Spruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting	NASDAQ:SPRB	Spruce Biosciences Inc
2024/04/23	05 : 05	Business Wire	Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting	NASDAQ:SPRB	Spruce Biosciences Inc
2024/03/14	05 : 08	Business Wire	Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates	NASDAQ:SPRB	Spruce Biosciences Inc
2024/03/14	05 : 01	Business Wire	Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH	NASDAQ:SPRB	Spruce Biosciences Inc
2024/03/08	06 : 07	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:SPRB	Spruce Biosciences Inc
2024/02/07	06 : 15	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:SPRB	Spruce Biosciences Inc
2024/01/31	06 : 05	Business Wire	Spruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:SPRB	Spruce Biosciences Inc
2024/01/22	22 : 00	Business Wire	Spruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal Hyperplasia	NASDAQ:SPRB	Spruce Biosciences Inc
2024/01/08	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SPRB	Spruce Biosciences Inc
2024/01/05	22 : 00	Business Wire	Spruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAH	NASDAQ:SPRB	Spruce Biosciences Inc
2024/01/04	22 : 00	Business Wire	Spruce Biosciences Provides Clinical Program Updates and Outlook for 2024	NASDAQ:SPRB	Spruce Biosciences Inc
2024/01/04	06 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SPRB	Spruce Biosciences Inc
2023/12/19	10 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SPRB	Spruce Biosciences Inc
2023/12/19	10 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SPRB	Spruce Biosciences Inc
2023/11/29	09 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SPRB	Spruce Biosciences Inc
2023/11/14	06 : 22	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SPRB	Spruce Biosciences Inc
2023/11/14	06 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SPRB	Spruce Biosciences Inc